SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-007547
Filing Date
2022-05-05
Accepted
2022-05-05 06:57:30
Documents
58
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q krtx-20220331.htm   iXBRL 10-Q 1807099
2 EX-31.1 krtx-ex31_1.htm EX-31.1 17671
3 EX-31.2 krtx-ex31_2.htm EX-31.2 16943
4 EX-32.1 krtx-ex32_1.htm EX-32.1 16926
  Complete submission text file 0000950170-22-007547.txt   6986075

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT krtx-20220331_cal.xml EX-101.CAL 58265
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT krtx-20220331.xsd EX-101.SCH 50109
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT krtx-20220331_pre.xml EX-101.PRE 278919
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT krtx-20220331_lab.xml EX-101.LAB 401497
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT krtx-20220331_def.xml EX-101.DEF 140109
52 EXTRACTED XBRL INSTANCE DOCUMENT krtx-20220331_htm.xml XML 1308946
Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38958 | Film No.: 22893935
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences